Remove 2017 Remove FDA Remove Immunization
article thumbnail

The future of pain medication: are cannabinoids the solution to the opioid epidemic?

Pharmaceutical Technology

In 2022, the FDA awarded VX-548 breakthrough therapy and fast-track designations for post-operative pain, and the drug is forecast to reach sales of $416m by 2029. CB1 is predominantly found in the central and peripheral nervous system, whereas CB2 is primarily located in immune cells.

article thumbnail

7 health benefits of raspberry leaf tea

The Checkup by Singlecare

Antioxidants are often associated with a healthy immune system, but they may also stave off disease by protecting cells from damage caused by free radicals. A 2017 study demonstrated that ellagic acid can inhibit pancreatic cancer growth. Does raspberry leaf interfere with medications?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Janssen files its first CAR-T therapy cilta-cel in Europe

pharmaphorum

The BCMA-targeting CAR-T – also known as cilta-cel – has been filed with the EMA as a treatment for adults with relapsed/refractory multiple myeloma, an incurable form of blood cancer, a few months after it was submitted to the FDA for the same indication. BMS and bluebird had been hoping for a label allowing third-line use.

article thumbnail

The top 5 pharma M&A deals of 2020

pharmaphorum

California-based Gilead announced its strong intentions in oncology in 2017 with its $11.9 Sanofi’s acquisition builds on a partnership to develop central nervous system drugs that began in late 2017. billion buy of Kite Pharma and followed that earlier this year by acquiring immuno-oncology firm Forty Seven for $4.9

article thumbnail

Merck pulls Keytruda’s FDA nod for third-line stomach cancer

pharmaphorum

The decision comes after FDA advisors voted six to two in April that Keytruda (pembrolizumab) should not stay on the market as a treatment option for patients with PD-L1-expressing gastric or gastroesophageal junction (GEJ) adenocarcinoma in patients who have received two or more earlier lines of therapy.

FDA 52
article thumbnail

Transforming oncology with antibody therapeutics

European Pharmaceutical Review

Overall, the mechanisms of action for amivantamab include ligand blocking, receptor degradation, and immune cell-mediated activity. 4 BsMAb amivantamab was designed to enhance adherence of tumour cells to macrophages and natural killer cells, to improve immune-cell mediated killing of cancer cells. 2017; 8(43): 75712–26.

article thumbnail

How to choose a nasal spray for allergies

The Checkup by Singlecare

Steroid sprays All steroid nasal sprays previously required a prescription from your healthcare provider, but some have since received FDA approval for OTC use, such as Flonase (fluticasone propionate), Nasacort (triamcinolone), Nasonex (mometasone), and Rhinocort (budesonide). Others are still available with prescription only.